Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Categories

  • ABB
  • Alps
  • Basel
  • Bern
  • Chubb
  • Geneva
  • Glencore
  • Lausanne
  • Nestlé
  • Novartis
  • Roche
  • Switzerland
  • UBS
  • Vitol
  • Zürich
  • Zurich Insurance
Switzerland
  • Europe
    • FR
    • DE
    • IT
    • ES
    • BE
    • NL
    • LU
    • DK
    • PL
    • UK
  • Switzerland
    • Basel
    • Bern
    • Geneva
    • Lausanne
    • Zürich
  • Schweiz
  • Suisse
  • Alps
  • Business
    • ABB
    • Chubb
    • Glencore
    • Nestlé
    • Novartis
    • Roche
    • UBS
    • Vitol
    • Zurich Insurance
  • NATO
  • US
  • Africa
  • Afrique

Browsing Tag

Allschwil

4 posts
BBasel
Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting
Read More

Basilea shareholders approve all proposals of the board of directors at the 2026 annual general meeting

  • 2026-04-16
Basilea Pharmaceutica International Ltd, Allschwil Allschwil, Switzerland, April 15, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX: BSLN), a commercial-stage…
BBasel
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Read More

Basilea awarded additional CARB-X funding of USD 6 million

  • 2026-04-11
Funding is awarded following successful completion of IND-enabling studies and clinical study authorization USD 6 million in additional funding…
BBasel
Basilea reports strong 2025 full-year results, surpassing revenue and operating profit guidance
Read More

Basilea awarded additional CARB-X funding of USD 6 million to support the clinical development of antibiotic BAL2420

  • 2026-04-09
Basilea Pharmaceutica International Ltd, Allschwil Funding is awarded following successful completion of IND-enabling studies and clinical study authorization …
BBasel
Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea
Read More

Basilea receives further USD 6 million from BARDA to

  • 2026-02-25
Ad hoc announcement pursuant to Art. 53 LR Allschwil, Switzerland, February 25, 2026 Basilea Pharmaceutica Ltd, Allschwil (SIX:…
Switzerland
www.europesays.com